Decode Health was recently recognized with an AI Innovator Award at the DataRobot AIX 22 global virtual conference. DataRobot is a Boston-based AI cloud platform company that works with customers worldwide across industries and verticals, including almost 40% of Fortune 50 companies.
Autoimmune diseases, such as multiple sclerosis (MS), ulcerative colitis, Crohn’s disease, and rheumatoid arthritis, are complex diseases that affect over four million people in the United States and cost the healthcare system over $90 billion [read more...]
The SARS-CoV-2 (COVID-19) pandemic has exposed health disparities throughout the USA, particularly among racial and ethnic minorities. As a result, there is a need for data-driven approaches to pinpoint the unique constellation of clinical and social determinants of health (SDOH) risk factors that give rise to poor patient outcomes following infection in US communities.
The SARS-CoV-2 (COVID-19) pandemic has exposed the need to understand the risk drivers that contribute to uneven morbidity and mortality in US communities. Addressing the community-specific social determinants of health (SDOH) that correlate with spread of SARS-CoV-2 provides an opportunity for targeted public health intervention to promote greater resilience to viral respiratory infections.
According to an article in the Journal of the American Medical Association (JAMA), two Harvard economists estimate the cumulative financial costs of the COVID-19 pandemic at more than $16 trillion. To put this number into perspective, that’s approximately 90% of annual GDP of the United States or $200,000 for a family of four. This is a combination of lost income due to the COVID-induced recession and the economic effect of a shorter, less healthy life.
Just as national health officials warned ahead of the holiday season, the winter months of 2020-21 have proven to be the most challenging period of the COVID-19 pandemic so far. In Tennessee alone, there have [read more...]
As featured on tennesseelookout.com Decode Health had been subleasing office space in Cummins Station in Nashville when Covid-19 forced the team home in March. The company, which provides predictive disease insights to national laboratories, moved [read more...]
Although COVID-19 hospitalizations and death rates have dominated the media, another challenge has quietly emerged during the pandemic. Some COVID patients are reporting a wide variety of debilitating symptoms, often lasting months after being diagnosed. [read more...]
New members bring cross-industry insights to the company Nashville, Tenn. – Nov. 11, 2020 – Chase Spurlock, PhD, founder and CEO of Decode Health, announced the addition of two members to the company's Strategic Advisory Board. [read more...]
One-year-old technology startup Decode Health has developed a predictive artificial intelligence platform that identifies emerging trends in the COVID-19 outbreak, providing governments and other organizations early insights to where resources need to be allocated to provide targeted outreach among high-risk populations.
